waypoint wealth counsel Buys New Stake in UiPath, Inc. $PATH

waypoint wealth counsel bought a new stake in shares of UiPath, Inc. (NYSE:PATH) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,614 shares of the company’s stock, valued at approximately $174,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of UiPath by 3.0% in the first quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company’s stock worth $495,029,000 after acquiring an additional 1,396,972 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of UiPath by 10.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,132,003 shares of the company’s stock worth $63,164,000 after acquiring an additional 602,866 shares during the period. Federated Hermes Inc. raised its position in shares of UiPath by 479.3% in the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company’s stock worth $58,917,000 after acquiring an additional 4,732,712 shares during the period. Acadian Asset Management LLC raised its position in shares of UiPath by 222.6% in the first quarter. Acadian Asset Management LLC now owns 4,241,047 shares of the company’s stock worth $43,667,000 after acquiring an additional 2,926,263 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of UiPath by 6.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,995,632 shares of the company’s stock worth $30,855,000 after acquiring an additional 177,071 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Brad Brubaker sold 66,665 shares of the company’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $15.00, for a total transaction of $999,975.00. Following the completion of the sale, the insider owned 690,519 shares of the company’s stock, valued at approximately $10,357,785. This represents a 8.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Daniel Dines sold 122,734 shares of the company’s stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $18.37, for a total transaction of $2,254,623.58. Following the sale, the chief executive officer directly owned 490,936 shares of the company’s stock, valued at approximately $9,018,494.32. This represents a 20.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,725,068 shares of company stock valued at $22,742,192. 23.19% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on PATH shares. BMO Capital Markets upped their price objective on shares of UiPath from $12.50 to $13.00 and gave the stock a “market perform” rating in a research report on Thursday, October 2nd. Canaccord Genuity Group decreased their price objective on shares of UiPath from $16.00 to $15.00 and set a “buy” rating for the company in a research report on Monday, September 8th. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a research report on Friday, September 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of UiPath in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded shares of UiPath from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 8th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $13.21.

UiPath Stock Down 8.0%

PATH stock opened at $17.04 on Monday. The stock has a market capitalization of $9.05 billion, a P/E ratio of 567.83, a P/E/G ratio of 6.31 and a beta of 1.07. The firm has a 50-day simple moving average of $11.99 and a 200-day simple moving average of $12.04. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $18.74.

UiPath (NYSE:PATH) last released its earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.07. The business had revenue of $361.73 million during the quarter, compared to analysts’ expectations of $347.36 million. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The company’s quarterly revenue was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.